Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03343197
Title Study of AG-120 and AG-881 in Subjects With Low Grade Glioma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Agios Pharmaceuticals, Inc.
Indications

malignant astrocytoma

oligodendroglioma

Therapies

Ivosidenib

AG-881

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
United States, California Los Angeles California 90024 United States Details
United States, California San Francisco California 94143 United States Details
United States, Massachusetts Boston Massachusetts 02215 United States Details
United States, New York New York New York 10065 United States Details
United States, North Carolina Durham North Carolina 27710 United States Details
United States, Texas Dallas Texas 75390 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field